drugset / Trial / NCT00171132

VALENCE: Valsartan Versus Atenolol on Exercise Capacity in Hypertensive Overweight Postmenopausal Women

NCT00171132

Phase 4 Completed 64 enrolled Novartis
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of the study is to show that valsartan compared to atenolol has favorable effects on exercise capacity, quality of life, diastolic function and elevated blood pressure in hypertensive postmenopausal overweight women with impaired exercise tolerance despite normal left ventricular ejection fraction (LVEF).

Timeline

Start
2004-08
Primary completion
2007-08
Completion
2007-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Atenolol Other / unclassified
Subject Valsartan Small molecule
Background Hydrochlorothiazide Unknown

Indications